Cargando…
The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness?
The newly proposed Federal "Right to Try" Act permits terminally ill patients to try experimental therapies that have completed phase I testing but have not been approved by the FDA. However, there are concerning provisions of the legislature regarding liability and costs.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040874/ https://www.ncbi.nlm.nih.gov/pubmed/30018839 |